English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Illumina Searching For Expanding Gene Sequencing Market
2017-01-03
As a new type of genetic testing technology, Gene Sequencing analyzes and tests complete gene sequencing through blood or ptysma which can forecast the possibility of personal diseases and different kinds of behaviora..
Verily teams on heart disease R&D
2017-01-03
The American Heart Association (AHA), Verily (formerly Google Life Sciences) and AstraZeneca ($AZN) have chipped in a total of $75 million over 5 years to support "one brave idea from a visionary leader" to cure coronary heart disease.
Thermo Fisher to Acquire Affymetrix for $1.3B
2017-01-03
Thermo Fisher Scientific said after the close of the market Friday that it is acquiring Affymetrix for approximately $1.3 billion.
LEPU Planed To Purchase Cardiovascular Drug Enterprises & Hospitals
2017-01-03
Lepu Medical Technologies announced recently to prepare the big issue of acquisition with estimated amount of ¥650 million to ¥1.2 billion and the acquisition target embraced cardiovascular drug enterprises and hospitals.
The laboratory was revealed serious problems
2017-01-03
Now 2016 has come, but for Theranos, which was just revealed a serious fraud technically in 2015, the new year doesn’t seem good.
NeoGenomics Buys Clarient for Up to $275M
2017-01-03
NeoGenomics said today it has agreed to acquire Clarient and its wholly-owned subsidiary Clarient Diagnostic Services from GE Healthcare.
Jan Medical Finances to Develop Test Tools
2017-01-03
Jan medical, which is located in Mountain View, California, recently has raised $ 7.5 million from Germany, Brain lab medical company as the cost of the research and development of the diagnosis connected devices for nervous system diseases.
Abbott spends $5.8 billion to acquire Alere
2017-01-03
Recently, US pharmaceutical giant Abbott announced their acquisition of Alere Inc at the price of $56 per share, spending a total of $5.8 billion.
10x Genomics strikes deals with Illumina, Agilent and Qiagen
2017-01-03
10x Genomics has entered into collaborations with Illumina ($ILMN), Agilent Technologies ($A) and Qiagen ($QGEN).
Invivoscribe, Thermo Fisher Ink Cancer Dx Development Deal
2017-01-03
Recently, Invivoscribe Technologies announced that it has formed a strategic partnership with Thermo Fisher Scientific to develop multiple next-generation sequencing-based in vitro cancer diagnostics.
Livzon Develops joint Company for Tumor Test
2017-01-03
Livzon Pharmaceutical recently announced that its holding subsidiary Zhuhai Livzon Diagnostics Inc.
Gen9 Partners on Gene Synthesis
2017-01-03
DNA construction firm Gen9 and British synthetic biology network SynbiCite have announced a partnership to increase access to gene synthesis technology.
Thermo Fisher, CHLA Team on Pediatric Cancer NGS Panel
2017-01-03
Children's Hospital Los Angeles and Thermo Fisher Scientific announced today that they will partner to develop a next-generation sequencing-based gene panel for pediatric cancer research.
ISO13485-2016 I.General requirements
2017-01-03
4.1 General requirements 4.1.1 The organizationshall document a quality management system and maintain its effectiveness in accordancewith the requirements of this International Standard and applicable regulatoryrequirements.
Should There Have A Standard of NGS Dx?
2017-01-03
Christian Millare had a severe seizure on Jan. 5, 2008, and died. He was two years old. His mother Amy Williams is convinced, based on his medical records, the opinions of experts, and the published literature,
Total:
3209
Pages:
214
First
Prev
1
..
192
193
194
195
196
197
198
..
214
Next
End